RNA methyltransferase METTL16: Targets and function
- PMID: 34227247
- PMCID: PMC9286414
- DOI: 10.1002/wrna.1681
RNA methyltransferase METTL16: Targets and function
Abstract
The N6-methyladenosine (m6A) RNA methyltransferase METTL16 is an emerging player in the RNA modification landscape of the human cell. Originally thought to be a ribosomal RNA methyltransferase, it has now been shown to bind and methylate the MAT2A messenger RNA (mRNA) and U6 small nuclear RNA (snRNA). It has also been shown to bind the MALAT1 long noncoding RNA and several other RNAs. METTL16's methyltransferase domain contains the Rossmann-like fold of class I methyltransferases and uses S-adenosylmethionine (SAM) as the methyl donor. It has an RNA methylation consensus sequence of UACAGARAA (modified A underlined), and structural requirements for its known RNA interactors. In addition to the methyltransferase domain, METTL16 protein has two other RNA binding domains, one of which resides in a vertebrate conserved region, and a putative nuclear localization signal. The role of METTL16 in the cell is still being explored, however evidence suggests it is essential for most cells. This is currently hypothesized to be due to its role in regulating the splicing of MAT2A mRNA in response to cellular SAM levels. However, one of the more pressing questions remaining is what role METTL16's methylation of U6 snRNA plays in splicing and potentially cellular survival. METTL16 also has several other putative coding and noncoding RNA interactors but the definitive methylation status of those RNAs and the role METTL16 plays in their life cycle is yet to be determined. Overall, METTL16 is an intriguing RNA binding protein and methyltransferase whose important functions in the cell are just beginning to be understood. This article is categorized under: RNA Processing > RNA Editing and Modification RNA Interactions with Proteins and Other Molecules > RNA-Protein Complexes.
Keywords: METTL16; N6-methyladenosine; RNA binding; RNA methyltransferase; epitranscriptomics.
© 2021 The Authors. WIREs RNA published by Wiley Periodicals LLC.
Conflict of interest statement
The authors have declared no conflicts of interest for this article.
Figures
Similar articles
-
Characterization of METTL16 as a cytoplasmic RNA binding protein.PLoS One. 2020 Jan 15;15(1):e0227647. doi: 10.1371/journal.pone.0227647. eCollection 2020. PLoS One. 2020. PMID: 31940410 Free PMC article.
-
The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention.Cell. 2017 May 18;169(5):824-835.e14. doi: 10.1016/j.cell.2017.05.003. Cell. 2017. PMID: 28525753 Free PMC article.
-
Elucidating the Kinetic Mechanism of Human METTL16.Biochemistry. 2023 Jan 17;62(2):494-506. doi: 10.1021/acs.biochem.2c00601. Epub 2022 Dec 30. Biochemistry. 2023. PMID: 36584291 Free PMC article.
-
METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function.Int J Mol Sci. 2021 Feb 22;22(4):2176. doi: 10.3390/ijms22042176. Int J Mol Sci. 2021. PMID: 33671635 Free PMC article. Review.
-
The Role of the m6A RNA Methyltransferase METTL16 in Gene Expression and SAM Homeostasis.Genes (Basel). 2022 Dec 8;13(12):2312. doi: 10.3390/genes13122312. Genes (Basel). 2022. PMID: 36553579 Free PMC article. Review.
Cited by
-
METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.Int J Biol Sci. 2024 Feb 4;20(4):1471-1491. doi: 10.7150/ijbs.86719. eCollection 2024. Int J Biol Sci. 2024. PMID: 38385084 Free PMC article.
-
METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A/YTHDC2/SCD1-regulated lipid metabolism.Cell Mol Life Sci. 2024 Feb 9;81(1):81. doi: 10.1007/s00018-024-05146-x. Cell Mol Life Sci. 2024. PMID: 38334797 Free PMC article.
-
The role of RNA modification in urological cancers: mechanisms and clinical potential.Discov Oncol. 2023 Dec 20;14(1):235. doi: 10.1007/s12672-023-00843-8. Discov Oncol. 2023. PMID: 38117350 Free PMC article. Review.
-
m6A regulates breast cancer proliferation and migration through stage-dependent changes in Epithelial to Mesenchymal Transition gene expression.Front Oncol. 2023 Nov 7;13:1268977. doi: 10.3389/fonc.2023.1268977. eCollection 2023. Front Oncol. 2023. PMID: 38023205 Free PMC article.
-
The emerging role of m6A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review.Front Cell Dev Biol. 2023 Oct 30;11:1264552. doi: 10.3389/fcell.2023.1264552. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37965577 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
